Ginkgo Bioworks DNA Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Concentration risk percentage by Business | |||||
| Biosecurity | 12%-4.0pp | 16%+5.0pp | 11%0.0pp | 11%-6.0pp | |
| Cell Engineering | 15%-5.0pp | 20%+8.0pp | 12%— | —— | |
| Concentration risk by Product | |||||
| Consumer and technology | 9%— | —— | —— | —— | |
| Government and defense | 67%— | —— | 16%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ginkgo Bioworks break its business down?
- Ginkgo Bioworks (DNA) reports concentration risk percentage by business across 2 parts — Biosecurity and Cell Engineering. Each is extracted from the segment footnotes and tracked over time.
- Where does Ginkgo Bioworks's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ginkgo Bioworks's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
